adenine has been researched along with Dysmyelopoietic Syndromes in 4 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Do patients with therapy-related acute myeloid leukemia (t-AML) have a poor prognosis independent of other predictive variables such as cytogenetics or molecular determinants? Limited data exist to answer this question in part because t-AML is often considered together with AML following myelodysplastic syndromes (MDS) in the category of secondary AML." | 1.37 | Does therapy-related AML have a poor prognosis, independent of the cytogenetic/molecular determinants? ( Feldman, EJ, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Perrard, N | 1 |
| Pokeerbux, MR | 1 |
| Quesnel, B | 1 |
| Duployez, N | 1 |
| Fenwarth, L | 1 |
| Preudhomme, C | 1 |
| Lefèvre, G | 1 |
| Baillet, C | 1 |
| Launay, D | 1 |
| Terriou, L | 1 |
| Huls, G | 1 |
| Chitu, DA | 1 |
| Pabst, T | 1 |
| Klein, SK | 1 |
| Stussi, G | 1 |
| Griskevicius, L | 1 |
| Valk, PJM | 1 |
| Cloos, J | 1 |
| van de Loosdrecht, AA | 1 |
| Breems, D | 1 |
| van Lammeren-Venema, D | 1 |
| van Zeventer, I | 1 |
| Boersma, R | 1 |
| Jongen-Lavrencic, M | 1 |
| Fehr, M | 1 |
| Hoogendoorn, M | 1 |
| Manz, MG | 1 |
| Söhne, M | 1 |
| van Marwijk Kooy, R | 1 |
| Deeren, D | 1 |
| van der Poel, MWM | 1 |
| Legdeur, MC | 1 |
| Tick, L | 1 |
| Chalandon, Y | 1 |
| Ammatuna, E | 1 |
| Blum, S | 1 |
| Löwenberg, B | 1 |
| Ossenkoppele, GJ | 1 |
| Jain, P | 1 |
| Feldman, EJ | 1 |
1 review available for adenine and Dysmyelopoietic Syndromes
| Article | Year |
|---|---|
Lenalidomide-induced acute liver failure.
Topics: Adenine; Aged, 80 and over; Antineoplastic Agents; Antiviral Agents; Hepatitis B, Chronic; Humans; L | 2009 |
1 trial available for adenine and Dysmyelopoietic Syndromes
| Article | Year |
|---|---|
Ibrutinib added to 10-day decitabine for older patients with AML and higher risk MDS.
Topics: Adenine; Decitabine; Humans; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Netherlands; Piper | 2020 |
2 other studies available for adenine and Dysmyelopoietic Syndromes
| Article | Year |
|---|---|
[GATA2 gene mutations: 3 cases].
Topics: Adenine; Adult; Female; GATA2 Transcription Factor; Humans; Immunologic Deficiency Syndromes; Leukem | 2022 |
Does therapy-related AML have a poor prognosis, independent of the cytogenetic/molecular determinants?
Topics: Adenine; Anthracyclines; Antineoplastic Agents; Biomarkers, Tumor; Cytarabine; Cytogenetics; Female; | 2011 |